GE HealthCare Technologies (GEHC) Net Income towards Common Stockholders (2022 - 2026)

GE HealthCare Technologies' Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at $411.0 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders fell 30.1% year-over-year to $411.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 billion (down 10.42% YoY) and the FY2025 annual result came in at $2.1 billion, up 4.57% from the prior year.
• Net Income towards Common Stockholders was $411.0 million for Q1 2026 at GE HealthCare Technologies, down from $602.0 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $721.0 million in Q4 2024 and bottomed at $189.0 million in Q1 2023.
• A 5-year average of $462.2 million and a median of $464.0 million in 2025 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders slumped 51.41% — and 2024, when it soared 97.88%.
• GE HealthCare Technologies' Net Income towards Common Stockholders stood at $554.0 million in 2022, then decreased by 27.26% to $403.0 million in 2023, then soared by 78.91% to $721.0 million in 2024, then dropped by 16.5% to $602.0 million in 2025, then plunged by 31.73% to $411.0 million in 2026.
• Business Quant data shows GEHC's Net Income towards Common Stockholders at $411.0 million in Q1 2026, $602.0 million in Q4 2025, and $464.0 million in Q3 2025.